Allurion Technologies (ALUR) Competitors $2.84 +0.08 (+2.71%) As of 01:46 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALUR vs. NVNO, HYPR, CTCX, ZYXI, TELA, NSPR, RBOT, MDAI, ICCM, and SURGShould you be buying Allurion Technologies stock or one of its competitors? The main competitors of Allurion Technologies include enVVeno Medical (NVNO), Hyperfine (HYPR), Carmell (CTCX), Zynex (ZYXI), TELA Bio (TELA), InspireMD (NSPR), Vicarious Surgical (RBOT), Spectral AI (MDAI), IceCure Medical (ICCM), and SurgePays (SURG). These companies are all part of the "medical equipment" industry. Allurion Technologies vs. Its Competitors enVVeno Medical Hyperfine Carmell Zynex TELA Bio InspireMD Vicarious Surgical Spectral AI IceCure Medical SurgePays enVVeno Medical (NASDAQ:NVNO) and Allurion Technologies (NYSE:ALUR) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership. Do insiders & institutionals hold more shares of NVNO or ALUR? 34.7% of enVVeno Medical shares are owned by institutional investors. Comparatively, 21.4% of Allurion Technologies shares are owned by institutional investors. 16.0% of enVVeno Medical shares are owned by insiders. Comparatively, 9.6% of Allurion Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility and risk, NVNO or ALUR? enVVeno Medical has a beta of 1.01, meaning that its stock price is 1% more volatile than the S&P 500. Comparatively, Allurion Technologies has a beta of -0.45, meaning that its stock price is 145% less volatile than the S&P 500. Is NVNO or ALUR more profitable? enVVeno Medical has a net margin of 0.00% compared to Allurion Technologies' net margin of -86.05%. Allurion Technologies' return on equity of 0.00% beat enVVeno Medical's return on equity.Company Net Margins Return on Equity Return on Assets enVVeno MedicalN/A -57.35% -53.49% Allurion Technologies -86.05%N/A -41.49% Does the media prefer NVNO or ALUR? In the previous week, enVVeno Medical and enVVeno Medical both had 1 articles in the media. Allurion Technologies' average media sentiment score of 0.00 beat enVVeno Medical's score of -0.60 indicating that Allurion Technologies is being referred to more favorably in the news media. Company Overall Sentiment enVVeno Medical Negative Allurion Technologies Neutral Which has better earnings & valuation, NVNO or ALUR? enVVeno Medical has higher earnings, but lower revenue than Allurion Technologies. enVVeno Medical is trading at a lower price-to-earnings ratio than Allurion Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioenVVeno MedicalN/AN/A-$21.82M-$1.20-4.06Allurion Technologies$32.11M0.66-$26.15M-$12.50-0.23 Do analysts recommend NVNO or ALUR? Allurion Technologies has a consensus price target of $22.83, suggesting a potential upside of 702.58%. Given Allurion Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Allurion Technologies is more favorable than enVVeno Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score enVVeno Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Allurion Technologies 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 SummaryAllurion Technologies beats enVVeno Medical on 9 of the 15 factors compared between the two stocks. Get Allurion Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ALUR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALUR vs. The Competition Export to ExcelMetricAllurion TechnologiesMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$21.22M$10.37B$5.48B$20.66BDividend YieldN/A2.00%4.71%3.67%P/E Ratio-0.2319.0628.7329.26Price / Sales0.6628.45439.6661.43Price / CashN/A22.1035.6823.31Price / Book-0.093.508.154.42Net Income-$26.15M$211.77M$3.25B$995.90M7 Day Performance4.21%-0.19%-0.99%-0.16%1 Month Performance13.35%3.14%5.25%-0.69%1 Year Performance-84.17%-10.48%28.32%15.58% Allurion Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALURAllurion Technologies1.708 of 5 stars$2.85+2.7%$22.83+702.6%-85.7%$21.22M$32.11M-0.23501News CoverageUpcoming EarningsGap UpNVNOenVVeno Medical0.3601 of 5 stars$5.17+4.2%N/A-3.4%$86.98MN/A-4.3830News CoverageEarnings ReportGap UpHYPRHyperfine0.8782 of 5 stars$1.10+1.9%$1.06-3.6%+3.4%$84.06M$12.89M-2.04190CTCXCarmellN/A$3.88-4.4%N/A+153.6%$81.11M$32.84K0.0014ZYXIZynex2.7962 of 5 stars$2.56-0.8%$5.50+114.8%-80.4%$78.02M$192.35M-10.67770TELATELA Bio2.5103 of 5 stars$1.90-1.0%$7.25+281.6%-56.4%$75.95M$69.30M-1.35120News CoverageUpcoming EarningsNSPRInspireMD3.6439 of 5 stars$2.44+0.4%$4.50+84.4%-17.2%$74.75M$7.03M-3.2550News CoverageRBOTVicarious Surgical0.9728 of 5 stars$9.79-12.7%$8.50-13.2%+53.3%$66.54MN/A-0.94210News CoverageUpcoming EarningsMDAISpectral AI2.4952 of 5 stars$2.75+5.8%$4.75+72.7%+59.3%$65.82M$29.58M-5.0983News CoveragePositive NewsICCMIceCure Medical2.6142 of 5 stars$1.03-3.7%$2.50+142.7%+45.9%$62.81M$3.29M-3.6860News CoverageSURGSurgePays2.9111 of 5 stars$2.83-3.7%$9.00+218.0%+18.6%$60.01M$60.88M-1.0140News CoverageUpcoming EarningsHigh Trading Volume Related Companies and Tools Related Companies enVVeno Medical Competitors Hyperfine Competitors Carmell Competitors Zynex Competitors TELA Bio Competitors InspireMD Competitors Vicarious Surgical Competitors Spectral AI Competitors IceCure Medical Competitors SurgePays Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ALUR) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredGuess Who the Gvt Could Partner With Next?The Government Just Made a $400M Bet. Who's Next? A $100 trillion wealth shift is quietly underway... and t...Stansberry Research | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allurion Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allurion Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
